These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9016896)

  • 81. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
    Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
    Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hepatitis B vaccine immunogenicity in patients with chronic HCV infection at one year follow-up: the effect of interferon-alpha therapy.
    Chlabicz S; Grzeszczuk A; Łapiński TW
    Med Sci Monit; 2002 May; 8(5):CR379-83. PubMed ID: 12011781
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.
    Krawczyk A; Ludwig C; Jochum C; Fiedler M; Heinemann FM; Shouval D; Roggendorf M; Roggendorf H; Lindemann M
    Vaccine; 2014 Sep; 32(39):5077-82. PubMed ID: 24975813
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Vaccination Against Hepatitis B Virus (HBV) in HIV-1-Infected Patients With Isolated Anti-HBV Core Antibody: The ANRS HB EP03 CISOVAC Prospective Study.
    Piroth L; Launay O; Michel ML; Bourredjem A; Miailhes P; Ajana F; Chirouze C; Zucman D; Wendling MJ; Nazzal D; Carrat F; Rey D; Binquet C;
    J Infect Dis; 2016 Jun; 213(11):1735-42. PubMed ID: 26768256
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection.
    Böcher WO; Herzog-Hauff S; Herr W; Heermann K; Gerken G; Meyer Zum Büschenfelde KH; Löhr HF
    Clin Exp Immunol; 1996 Jul; 105(1):52-8. PubMed ID: 8697635
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Circulating Interferon-
    Grzegorzewska AE; Świderska MK; Mostowska A; Jagodziński PP
    Biomed Res Int; 2017; 2017():3713025. PubMed ID: 29226133
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Immune response after vaccination with recombinant hepatitis surface antigen in maintenance hemodialysis patients and healthy controls.
    Allegra V; Vasile A; Maschio M; Mengozzi G
    Nephron; 1992; 61(3):339-40. PubMed ID: 1386908
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Humoral immune response after hepatitis-B-vaccination: kinetics of anti-HBs antibodies and demonstration of HLA antigens.
    Usonis V; Kühnl P; Brede HD; Doerr HW
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Sep; 262(3):377-84. PubMed ID: 2947409
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better.
    DaRoza G; Loewen A; Djurdjev O; Love J; Kempston C; Burnett S; Kiaii M; Taylor PA; Levin A
    Am J Kidney Dis; 2003 Dec; 42(6):1184-92. PubMed ID: 14655190
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The antibody response to hepatitis B virus vaccination is negatively influenced by the hepatitis C virus viral load in patients with chronic hepatitis C: a case-control study.
    Leroy V; Bourliere M; Durand M; Abergel A; Tran A; Baud M; Botta-Fridlund D; Gerolami A; Ouzan D; Halfon P; Zarski JP
    Eur J Gastroenterol Hepatol; 2002 May; 14(5):485-9. PubMed ID: 11984145
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination.
    Hess G; Hingst V; Cseke J; Bock HL; Clemens R
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):334-40. PubMed ID: 1396753
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Hepatitis B virus vaccine immune response and mortality in dialysis patients: a meta-analysis.
    Udomkarnjananun S; Takkavatakarn K; Praditpornsilpa K; Nader C; Eiam-Ong S; Jaber BL; Susantitaphong P
    J Nephrol; 2020 Apr; 33(2):343-354. PubMed ID: 31701375
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Adjuvanted recombinant HBV vaccine (HBV-AS04) is effective over extended follow-up in dialysis population. An open-label non randomized trial.
    Fabrizi F; Cerutti R; Garcia-Agudo R; Bellincioni C; Porata G; Frontini G; Aoufi-Rabih S; Messa P
    Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):905-912. PubMed ID: 32144074
    [TBL] [Abstract][Full Text] [Related]  

  • 95. High dose hepatitis B vaccine is not effective in patients using immunomodulatory drugs: a pilot study.
    Haykir Solay A; Eser F
    Hum Vaccin Immunother; 2019; 15(5):1177-1182. PubMed ID: 30676860
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A prospective study of in vitro anti-HBs producing B cells (spot-ELISA) following primary and supplementary vaccination with a recombinant hepatitis B vaccine in insulin dependent diabetic patients and matched controls.
    Wismans PJ; van Hattum J; de Gast GC; Bouter KP; Diepersloot RJ; Maikoe T; Mudde GC
    J Med Virol; 1991 Nov; 35(3):216-22. PubMed ID: 1839554
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A new pre-S containing recombinant hepatitis B vaccine and its effect on non-responders: a preliminary observation.
    Yap I; Chan SH
    Ann Acad Med Singap; 1996 Jan; 25(1):120-2. PubMed ID: 8779530
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patients.
    Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
    World J Gastroenterol; 2014 Sep; 20(34):12018-25. PubMed ID: 25232238
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Immune response to hepatitis B vaccine in haemodialysis patients.
    Shatat HZ; Kotkat AM; Farghaly AG
    J Egypt Public Health Assoc; 2000; 75(3-4):257-75. PubMed ID: 17216922
    [TBL] [Abstract][Full Text] [Related]  

  • 100. HBV vaccination with Fendrix is effective and safe in pre-dialysis CKD population.
    Fabrizi F; Cerutti R; Nardelli L; Tripodi F; Messa P
    Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):49-56. PubMed ID: 31327620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.